Effective induction of melanoma-antigen-specific CD8+T cells via Vγ9γδT cell expansion by CD56high+Interferon-α-induced dendritic cells

Interleukin-23 Promotes Interferon-α Responsiveness in Hepatitis C Virus/HIV-Coinfected Patients

(2014) Madeline Odigie et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Ultraviolet light protection by a sunscreen prevents interferon-driven skin inflammation in cutaneous lupus erythematosus

(2014) Sabine Zahn et al.   EXPERIMENTAL DERMATOLOGY

Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C

(2014) Zhengxiao Li et al.   JOURNAL OF CLINICAL VIROLOGY

IFN-  Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo

(2014) C. Papewalis et al.   JOURNAL OF IMMUNOLOGY

PEG-IFN Alpha but Not Ribavirin Alters NK Cell Phenotype and Function in Patients with Chronic Hepatitis C

(2014) Antoaneta A. Markova et al.   PLoS One

Subtypes of type I IFN differentially enhance cytokine expression by suboptimally stimulated CD4+T cells

(2013) Philippa Hillyer et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Phase II Pilot Study of Intravenous High-Dose Interferon With or Without Maintenance Treatment in Melanoma at High Risk of Recurrence

(2013) Miranda J. Payne et al.   JOURNAL OF CLINICAL ONCOLOGY

Type 1 IFN-induced protein MxA and plasmacytoid dendritic cells in lesions of morphea

(2012) Mehran Ghoreishi et al.   EXPERIMENTAL DERMATOLOGY

IFN-  enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing

(2011) F. Spadaro et al.   BLOOD

Interferon-α in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology

(2011) Á. Farkas et al.   BRITISH JOURNAL OF DERMATOLOGY

Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha

(2011) Els M. E. Verdegaal et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Zoledronic acid modulates maturation of human monocyte-derived dendritic cells

(2011) Giulia Orsini et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross-Talk between V 9V 2 T Cells,    CD8+ T Cells, Regulatory T Cells, and Dendritic Cells

(2011) B. Castella et al.   JOURNAL OF IMMUNOLOGY

CD56+ human blood dendritic cells effectively promote TH1-type    T-cell responses

(2009) G. Gruenbacher et al.   BLOOD

Control of CD56 expression and tumor cell cytotoxicity in human Vγ2Vδ2 T cells

(2009) Elizabeth M Urban et al.   BMC IMMUNOLOGY

Isopentenyl Pyrophosphate-Activated CD56+    T Lymphocytes Display Potent Antitumor Activity toward Human Squamous Cell Carcinoma

(2008) A. A.Z. Alexander et al.   CLINICAL CANCER RESEARCH

STAT3 as a Biomarker of Progression in Atypical Nevi of Patients with Melanoma: Dose–Response Effects of Systemic IFNα Therapy

(2008) Wenjun Wang et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY